BioCardia, Inc. Quarterly Costs and Expenses in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
BioCardia, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2016 to Q2 2024.
  • BioCardia, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $1.65M, a 52.7% decline year-over-year.
  • BioCardia, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $9.03M, a 32.9% decline year-over-year.
  • BioCardia, Inc. annual Costs and Expenses for 2023 was $12.1M, a 8.54% decline from 2022.
  • BioCardia, Inc. annual Costs and Expenses for 2022 was $13.3M, a 2.87% decline from 2021.
  • BioCardia, Inc. annual Costs and Expenses for 2021 was $13.6M, a 12.9% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.03M $1.65M -$1.84M -52.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $10.9M $2.33M -$1.24M -34.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $12.1M $2.1M -$1.03M -32.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $13.1M $2.96M -$317K -9.69% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $13.5M $3.5M +$25K +0.72% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $13.4M $3.57M +$187K +5.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $13.3M $3.12M -$416K -11.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $13.7M $3.27M -$257K -7.28% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $13.9M $3.47M -$88K -2.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $14M $3.39M +$369K +12.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $13.6M $3.54M -$4K -0.11% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $13.6M $3.53M -$353K -9.09% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $14M $3.56M -$43K -1.19% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $14M $3.02M -$1.63M -35.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $15.7M $3.54M -$207K -5.52% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $15.9M $3.88M +$461K +13.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $15.4M $3.6M -$247K -6.42% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $15.7M $4.65M +$744K +19.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $14.9M $3.75M -$12K -0.32% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $14.9M $3.42M -$233K -6.38% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $15.2M $3.85M +$357K +10.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $14.8M $3.9M +$84K +2.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $14.7M $3.76M +$140K +3.86% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-09
Q3 2018 $14.6M $3.65M +$485K +15.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $14.1M $3.49M +$411K +13.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $13.7M $3.82M +$807K +26.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $12.9M $3.62M +$14K +0.39% Oct 1, 2017 Dec 31, 2017 10-K 2020-04-09
Q3 2017 $12.9M $3.17M +$1.37M +76.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $11.5M $3.08M +$1.56M +102% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $9.94M $3.01M +$1.76M +140% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $8.18M $3.61M Oct 1, 2016 Dec 31, 2016 10-K 2019-04-02
Q3 2016 $1.8M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.52M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $1.25M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.